Genetics First Hashimoto's Treatment

Why do I feel like my thyroid medicine is not working?

By Marta Banuelos, MS | Functional Medicine Practitioner, Clinical Nutritionist

If you’ve found your way to this article, you’ve likely already exhausted the conventional path. You’ve sat in examination rooms describing symptoms that feel debilitating — fatigue, weight gain, hair loss, cognitive fog — only to be handed a lab report stamped “within normal limits.” Or perhaps you’ve received a Hashimoto’s diagnosis but remain symptomatic despite treatment which doesn’t seem to be working.

That experience is far more common than it should be. And it’s precisely why this question — can Hashimoto’s actually be treated at the root cause level? — deserves a thorough, clinically honest answer rather than a generalized one.

My short answer: for most patients, yes — when the root cause is properly identified at the genetic level and addressed with clinical precision. But the fuller answer requires important nuance, and that nuance is what this article is designed to provide.

Setting the Clinical Framework: Hypothyroidism vs. Hashimoto’s

Before we discuss treatment, we need to be precise about what we’re treating — because hypothyroidism and Hashimoto’s thyroiditis, while related, are not the same condition and do not carry the same prognosis or treatment requirements.

Hypothyroidism, depending on its underlying etiology, can often be meaningfully reversed through functional medicine when the root cause driving thyroid dysfunction is identified and resolved. This is not anecdotal — it is what I witness consistently in clinical practice when the right diagnostic workup is performed.

Hashimoto’s thyroiditis requires a more nuanced conversation. As an autoimmune condition, Hashimoto’s cannot be cured in the conventional sense — the genetic predisposition and immunological vulnerability that underlie the disease do not disappear. However, what I have seen repeatedly in practice, and what the functional medicine literature increasingly supports, is that autoimmune activity can be driven down substantially — to a state of true remission with no symptomatic expression. The disease risk may remain encoded in your genetics, but the clinical manifestation of that disease can be brought under control and maintained there with the right interventions.

This distinction is foundational to how I approach every patient. And it’s one most practitioners never clarify.

Where Conventional Medicine Falls Short

The standard of care for thyroid disease typically follows a predictable pattern: a TSH is ordered, a threshold is crossed, and thyroid hormone replacement is initiated. For many patients, this resolves the issue. For a significant number, it does not — and this is where the conventional model fails.

The limitations are structural. A TSH in isolation cannot reveal:

  • Whether peripheral conversion of T4 to the metabolically active T3 is occurring efficiently
  • Whether thyroid peroxidase (TPO), thyroglobulin (TgAb), or TSH receptor binding antibodies indicate active autoimmune involvement
  • Whether systemic inflammation, gut dysfunction, or nutrient depletion are the primary drivers of thyroid underperformance
  • Whether genetic variants are creating upstream or downstream roadblocks in thyroid hormone synthesis, conversion, or cellular utilization

That last point is the one most consistently overlooked — and, in my clinical experience, the one most consistently responsible for why patients remain symptomatic despite doing everything they’re told.

Patients who are prescribed thyroid hormone without this investigative foundation often remain symptomatic. They are not failing treatment. They are receiving incomplete treatment.

Why Genetics Is the Missing Piece

Here is what I have come to understand after years of working with Hashimoto’s patients: the reason generic protocols don’t work is not a matter of compliance or effort. It’s a matter of biology. Specifically, it’s a matter of your biology — which is encoded in your DNA and differs meaningfully from the patient sitting next to you with the same diagnosis.

Consider what genetics actually determines for a Hashimoto’s patient:

Whether your thyroid medication is reaching your cells. The DIO2 gene governs deiodinase enzyme activity — the mechanism by which your body converts T4 (the inactive thyroid hormone in most medications) into T3, the active form your cells can actually use. A variant in DIO2 is one of the most common — and most overlooked — explanations for why a patient’s TSH looks normal on paper while they feel exhausted, brain-fogged, and unable to lose weight. Their medication is circulating in their blood. Their cells cannot access it. Standard labs will never catch this.

Why your immune system keeps attacking your thyroid. The TNF-alpha and IL-6 genes regulate inflammatory signaling — the mechanism driving the autoimmune attack. HLA gene variants (specifically DQ2.5 and DQ8) determine your genetic predisposition to autoimmune reactivity and gluten sensitivity, which is directly linked to Hashimoto’s flares through a mechanism called molecular mimicry. Knowing your HLA status tells us how aggressively your immune system is wired to respond — and what interventions have the best chance of calming it.

Why standard supplements aren’t working for you. The VDR gene determines how well your body absorbs and utilizes vitamin D, a nutrient critical for immune regulation. GPX1 governs your selenium-dependent antioxidant capacity — selenium is one of the most important nutrients for thyroid hormone conversion. FADS1 and FADS2 determine how efficiently you process omega-3 fatty acids. This is the genetic explanation for why “take vitamin D, selenium, and fish oil” works for some Hashimoto’s patients and makes others feel no different: their genes determine what their body can and cannot absorb, activate, and use — and at what dose.

Why you cannot lose weight despite doing everything right. Variants in energy expenditure and metabolism-related genes mean your metabolism is genuinely running differently from what standard dietary advice assumes. This is not a willpower problem. It is a wiring problem.

Whether gluten elimination is actually necessary for your body specifically. If you carry HLA DQ2.5 or DQ8 variants, the connection between gluten, gut permeability, and autoimmune flares is written into your DNA — and gluten elimination is a clinical priority, not an optional lifestyle choice. If you don’t carry those variants, it may be one less restriction you need to live with.

How effectively your body manages methylation and detoxification. MTHFR variants impair B vitamin metabolism, homocysteine processing, and downstream immune and inflammatory regulation — all of which have direct implications for Hashimoto’s progression. GST and CYP enzyme variants affect your body’s detoxification capacity, which determines how well you clear the inflammatory burden that sustains autoimmune activity.

None of this information is available from a standard thyroid panel. All of it changes the treatment plan.

The Hashimoto’s Genetic Blueprint: What This Testing Actually Looks Like

The test I use with Hashimoto’s patients is the Hashimoto’s Genetic Blueprint — a comprehensive nutrigenomics assessment that analyzes 134+ genes across 36 health pathways, including thyroid conversion, immune regulation, inflammation, methylation, detoxification, fatty acid metabolism, and nutrient utilization.

It is not a consumer genetic test. It is not 23andMe. It is a clinical tool that can only be ordered through a certified practitioner — which means the results, and how to act on them, stay in the hands of someone trained to interpret them in the context of your full health picture.

It requires a simple cheek swab, done at home. Results come back in approximately four weeks. And what they reveal routinely explains — with genetic precision — why a patient has been feeling the way they do despite following every conventional recommendation.

This is not a test your doctor can order. It is not a test your doctor is trained to interpret. It is designed specifically for practitioners who work at the intersection of genomics and functional medicine — and it gives us a level of clinical specificity that no other entry point can provide.

The Root Cause Methodology: What a Complete Workup Looks Like

Genetics is the foundation. But a complete Hashimoto’s root cause investigation builds on that foundation with several additional layers of information — each one providing clinical context that the others cannot.

Comprehensive Gut Assessment. Thyroid health cannot be fully restored without addressing gut health. A significant proportion of T4-to-T3 conversion occurs in the gut. The gut mucosa is the primary site of immune education and regulation. Intestinal permeability is one of the most well-established environmental triggers for autoimmune disease initiation and progression. The gastrointestinal analysis I use evaluates the full microbial ecosystem — commensal and beneficial organisms, opportunistic and pathogenic bacteria, H. pylori with virulence factor profiling, parasitic organisms, fungal overgrowth, intestinal inflammation, mucosal immune function, and digestive absorptive capacity. This panel consistently identifies disruptions that directly drive — or perpetuate — autoimmune thyroid disease.

Food Sensitivity and Immune Reactivity Testing. The panel I use assesses reactivity across 88+ foods through four distinct immune pathways: IgE, IgG, IgG4, and C3 complement. C3 complement measurement is particularly important in autoimmune cases — complement-mediated inflammatory reactions are often missed entirely by IgG-only testing. Rather than restricting foods arbitrarily, this test identifies what is genuinely driving immune reactivity — allowing us to expand your dietary framework based on your actual immune profile, not a generalized elimination protocol.

Functional Thyroid and Autoimmune Panels. A meaningful thyroid assessment extends well beyond TSH. The panel I use includes TSH, Free T3, Free T4, Total T3, Reverse T3, TPO antibodies, thyroglobulin antibodies, and TSH receptor binding antibodies — the marker that most clinicians never order, yet which is essential for understanding the full autoimmune picture. Alongside this I assess hs-CRP and ANA screening for systemic inflammatory burden, a comprehensive metabolic panel, HbA1c, and a full blood count to identify anemia patterns that directly impact thyroid hormone metabolism. With 20+ markers, this workup routinely uncovers thyroid dysfunction that a TSH alone would entirely miss.

The genetic blueprint is what tells us why you developed Hashimoto’s and why it has persisted. The panels above tell us the current state of the systems your genetics are operating through. Together, they produce a treatment plan that is built entirely from your individual biology — not a generalized Hashimoto’s protocol that may or may not apply to you.

A Critical Note on Natural Interventions

One of the most important — and most frequently overlooked — principles in Hashimoto’s care is this: indiscriminate supplementation can worsen the very conditions it is intended to address.

This is particularly relevant in autoimmune thyroid disease. Excessive iodine intake has been shown to exacerbate autoimmune activity in Hashimoto’s patients. Selenium in excess impairs immune function. Zinc over-supplementation displaces copper and disrupts broader metabolic balance. The wellness landscape is full of generalized thyroid protocols that take no account of an individual’s actual deficiency status, genetic context, or immune presentation.

My approach is always genetics-informed and test-first. The genetic blueprint tells us what your body can and cannot process at the cellular level. The lab panels tell us where actual deficiencies exist. We replete those deficiencies with clinical specificity, at doses that are appropriate for your genetic expression. That is what produces resolution — not generalized supplementation stacks built for someone else’s biology.

The same principle applies to dietary intervention. Whether gluten elimination, AIP, or other dietary modifications are appropriate for you is determined by your genetics and your immune reactivity profile — not by what worked for the patient in the forum you found at 2am. My goal is to build a nutritional framework that supports what your biochemistry requires, not what a protocol assumes it does.

Clinical Cases: Why Genetics Changes Everything

Case One: Twenty Years of Unresolved Weight Gain

This patient presented with a twenty-year history of failed weight loss despite consistent effort. Her primary care physician was recommending thyroid hormone replacement, and she came to me seeking to understand the underlying cause before accepting a prescription she wasn’t convinced she needed.

Her initial labs contained a TSH and little else. I expanded the workup to include the full thyroid panel and antibody assessment. The results confirmed what her clinical picture suggested: Hashimoto’s thyroiditis, with elevated TPO and thyroglobulin antibodies indicating active autoimmune involvement.

Genetic analysis revealed HLA DQ2.5 variants — indicating significant autoimmune and gluten sensitivity predisposition. Food sensitivity and immune reactivity testing confirmed the clinical picture: a pattern of significant immune reactivity that, upon further investigation, led to a confirmed diagnosis of celiac disease — a condition that had been silently perpetuating intestinal inflammation, nutrient malabsorption, and immune dysregulation for years. The well-documented molecular mimicry between gliadin peptides and thyroid tissue meant her immune system had been in a state of chronic activation directly sustaining the autoimmune attack on her thyroid.

Her genetics told us why she had developed this pattern. Her immune testing told us where the active triggers were. By addressing both — resolving the celiac diagnosis and eliminating the identified immune reactivities — we progressively reduced her autoimmune burden. Antibody levels declined. Her Hashimoto’s moved down the autoimmune spectrum. Symptomatic expression diminished significantly. After twenty years of searching for answers, she achieved meaningful clinical resolution — without the thyroid hormone replacement that had been presented as her only option.

Case Two: When the Thyroid Is the Symptom, Not the Cause

This case illustrates one of the most important clinical principles in functional medicine: thyroid dysfunction is not always primary.

The patient presented with substantial unexplained weight gain and a constellation of symptoms that had been evaluated by multiple providers without resolution. Standard thyroid testing had identified hypothyroidism, but pharmacological treatment had produced minimal improvement — because the hypothyroidism itself was a downstream consequence of a more fundamental physiological disruption.

Comprehensive evaluation, including genetic analysis, revealed a variant directly impairing immune system regulation alongside concurrent B12, folate, and iron deficiency anemias. One of the identified anemias was blocking the hydroxylation of vitamin D into its bioactive form — creating functional vitamin D deficiency that profoundly dysregulated immune function. A chronically dysregulated immune system had created the conditions for thyroid dysfunction to develop and persist.

Her VDR variants, identified through genetic testing, compounded the vitamin D picture further. Her GPX1 status told us her antioxidant capacity was compromised — meaning oxidative stress at the thyroid level was higher than her body could defend against without targeted support.

Resolution required addressing the full root cause architecture: correcting the anemias, providing targeted genomic support for her specific variants, and rebuilding gut function as the foundation for sustained nutritional absorption. As the anemias resolved, immune regulation normalized. As immune function was restored, thyroid cell function recovered alongside it. Her thyroid was not the origin of her illness. It was the expression of it. Her genetics told us exactly where to look — and treating TSH in isolation would have left every underlying driver completely intact.

The Role of Thyroid Hormone Replacement in a Genetics-Guided Framework

Functional medicine and conventional endocrinology are not mutually exclusive. There are clinical circumstances in which thyroid hormone replacement is appropriate, necessary, and beneficial — and I want to be explicit about that.

When TSH is significantly elevated, I refer to endocrinology to ensure the patient has access to pharmacological support while we simultaneously pursue root cause investigation. Medication can serve as an important clinical bridge — stabilizing thyroid function and improving quality of life in the near term while the deeper work is underway.

What the genetic blueprint frequently clarifies is which medication and what dose — because knowing a patient’s DIO2 status changes the medication conversation significantly. A patient with confirmed DIO2 conversion impairment may do substantially better on combination T4/T3 therapy rather than T4 monotherapy alone. This is a conversation that cannot happen without genetic data. Most practitioners never have it.

What This Means for Your Care

Whether you are newly diagnosed, still searching for a diagnosis, or frustrated by treatment that has not delivered the resolution you were promised, the clinical message is consistent: comprehensive, genetics-guided testing changes outcomes.

When we understand your genetic blueprint — your conversion pathways, your immune wiring, your nutrient utilization, your inflammatory genetics — we stop estimating and start treating with precision. That is what produces the kind of resolution that generalized protocols cannot, because it is built entirely around your specific biochemistry rather than a standardized algorithm.

You have not failed to get better. The investigation has simply been incomplete.

Ready to Find Your Root Cause?

The Hashimoto’s Genetic Blueprint is the starting point for every patient I work with — because until we know what your genetics are actually doing, we are guessing. And guessing has already cost you enough time.

The best first step is a conversation.

In a Hashimoto’s Root Cause Consultation — a private 45-minute session — I walk you through which genetic pathways are most relevant to your specific symptom picture, and show you exactly what the Hashimoto’s Genetic Blueprint would reveal about your case. Most patients tell me it’s the first time they’ve felt genuinely understood. You’ll leave with clarity on why you’ve been feeling this way and a clear, confident decision about your next step.

Book My Hashimoto’s Root Cause Consultation — $147 

Marta Banuelos, MS, is a Functional Medicine Practitioner, Clinical Nutritionist, and IFM-Certified practitioner specializing in Hashimoto’s thyroiditis and autoimmune care. She specializes in the interpretation of the Hashimoto’s Genetic Blueprint — and practices via telehealth at Smarta Functional Medicine.